Akari Therapeutics Plc (AKTX)

5.50 +0.10 (+1.85%) USD  |  NASDAQ  |  May 01, 16:00
6.00 +0.50 (+9.09%) After-Hours: 19:46
More

Akari Therapeutics Research and Development Expense (% of Annual Revenues)

Research and Development Expense (% of Annual Revenues) Chart

View Research and Development Expense (% of Annual Revenues) for AKTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (% of Annual Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (% of Annual Revenues) Range, Past 5 Years

View Research and Development Expense (% of Annual Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (% of Annual Revenues) Benchmarks

View Research and Development Expense (% of Annual Revenues) Benchmarks
Start Trial
DBV Technologies SA --
Cellectis SA Upgrade
Biodexa Pharmaceuticals Plc --
Mereo BioPharma Group Plc Upgrade
Evaxion AS Upgrade